Eli Lilly launches new form of obesity drug Zepbound
Digest more
Add Yahoo as a preferred source to see more of our stories on Google. Shelby Knowles/Bloomberg via Getty A Zepbound injection pen. Eli Lilly’s weight loss drug Zepbound is no longer in short supply, the FDA said, worrying patients who use cheaper, off ...
The FDA has approved a label expansion for once-weekly tirzepatide for adults with overweight and obesity, allowing the medication to be used with a pen that is equipped with four doses of the drug, according to a press release.